Abstract:Yuting Luo, Rong Chen, Zhikun Ning, Nantao Fu, Minghao Xie Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China Correspondence: Minghao Xie Department of General Surgery, The First Affiliated Hospital of Nanchang University, 17 Yongwai Road, Nanchang, Jiangxi, 330006, People's Republic of China , Tel +8613672207521 , Email Purpose: Although well-differentiated papillary thyroid carcinoma (PTC) has an indolent nature and usually an excellent prognosis, some patients experience disease recurrence or death. The aim of this study was to identify prognostic markers to stratify PTC patients. Patients and Methods: Eight gene-expression profiles (GSE3467, GSE3678, GSE5364, GSE27155, GSE33630, GSE53157, GSE60542, and GSE104005) were obtained from the Gene Expression Omnibus and used to analyze differentially expressed genes (DEGs) between PTC tissues and non-tumor tissues. Univariable Cox regression survival analysis and Lasso-penalized Cox regression analysis were performed to identify prognostic genes and establish a risk-score model based on the integrated DEGs. Kaplan–Meier (KM) and receiver operating characteristic (ROC) curves were used to validate the prognostic performance of the risk score. A nomogram was constructed based on The Cancer Genome Atlas dataset and Multivariable Cox regression analysis. Results: A total of 165 upregulated and 207 downregulated DEGs were screened. A four-gene signature including PAPSS2, PCOLCE2, PTX3, and TGFBR3 was identified. The risk-score model showed a strong diagnosis performance for identifying patients with a poor prognosis. KM analysis showed that patients with low risk scores had a significantly more favorable overall survival (OS) than those with high risk scores (p = 0.0002). ROC curves based on the four-gene signature showed better performances in predicting 1-, 3-, and 5-year survival than did the American Joint Committee on Cancer staging system (area under the curve: 0.86 vs 0.84, 0.80 vs 0.63, and 0.79 vs 0.73, respectively). Furthermore, when combined with age and tumor status from the nomogram, the four-gene signature achieved a good performance in guiding postoperative follow-up surveillance of patients with PTC. Conclusion: The four-gene signature was found to be a novel and reliable biomarker with great potential for clinical application in risk stratification and OS prediction in patients with PTC. Keywords: gene signature, overall survival, papillary thyroid cancer, prognosis Thyroid carcinoma (THCA) is the most common type of endocrine malignancy and its incidence is increasing. 1 Based on its histopathological characteristics, thyroid carcinoma can be classified into multiple subtypes, such as papillary thyroid carcinoma (PTC), follicular thyroid carcinoma, and anaplastic thyroid carcinoma. 2 PTC is the most common subtype of THCA, comprising approximately 80% of all thyroid malignancies. 3 The prognosis for patients with PTC is highly favorable, although more than 10% of patients eventually experience local or distant disease recurrence. 4 Those patients with potentially poor outcomes must be monitored and administered timely and effective treatments to prolong their survival and improve their quality of life. Therefore, it is necessary to identify effective prognostic biomarkers of PTC to accurately assess their prognosis and to stratify patients. At present, treatment options for PTC and disease prognosis depend mainly on the histopathological subtype. Some variants of PTC may behave more aggressively than classic PTC. These so-called aggressive variants include the tall-cell variant, the columnar variant, the solid variant, and the recently described hobnail variant. The tall-cell variant is the most common aggressive variant of PTC. The tumor cells have typical nuclear features of PTC, composed of prominent papillary structures lined by cells 2 or 3 times as tall as they are wide, and have abundant eosinophilic (oncocytic-like) cytoplasm. The columnar variant can also be aggressive, particularly in older patients, with larger tumors, presenting symptomatically, and showing a diffusely infiltrative growth, and extrathyroidal extension. The solid variant not only has the same growth pattern with poorly differentiated THCA but also has the nuclear features of PTC. The histologic features of hobnail variant include papillary and micropapillary structures closely lined by cells containing eosinophilic cytoplasm and apically located nuclei with prominent nucleoli. The tumors cells have increased nuclear to cytoplasmic ratios and apically placed nuclei that produce a hobnail like surface bulge. 5 However, aggressive PTC variants re -Abstract Truncated-

Relationship of morphologic variants of papillary thyroid carcinoma and the prognosis

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

A population-based study of the three major variants of papillary thyroid carcinoma

Transition Analysis in the Clinicopathology and Prognosis of 2 682 Papillary Thyroid Carcinoma Cases over a 15-Year Period

Variant-related Clinicopathological Features in Papillary Thyroid Carcinoma: an Analysis of 600 Cases

Impact of Major Different Variants of Papillary Thyroid Microcarcinoma on the Clinicopathological Characteristics: the Study of 1041 Cases.

Multifocal Papillary Thyroid Carcinoma: Clinical Analysis of 168 Cases

Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma.

Subclassification of Non‐solid‐type Papillary Thyroid Carcinoma Identification of High‐risk Group in Common Type

Predictive Factors and Clinicopathological Characteristics of Outcome in Poorly Differentiated Thyroid Carcinoma: a Single-Institution Study.

Subclassification Of Non-Solid-Type Papillary Thyroid Carcinoma Identification Of High-Risk Group In Common Type (Vol 99, Pg 1908, 2008)

A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis

Identification of a Four-Gene Signature for Determining the Prognosis of Papillary Thyroid Carcinoma by Integrated Bioinformatics Analysis

Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.

Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group

Study on invasive histopathological features of papillary thyroid carcinoma with tall cell variant

Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study

A Retrospective Case-control Study of Tumor Characteristics of Coexistent Papillary Thyroid Carcinoma Diagnosed in Surgically Treated Patients for Secondary Hyperparathyroidism: Higher Incidence and More Often Occult Papillary Thyroid Carcinoma

Morphological changes, gene expression and prognosis in papillary thyroid carcinoma

Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer

Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis